Rave Kratom Targeted Kratom Extract Gummies NUMB 250mg

Description

Rave Kratom Targeted Kratom Extract Gummies NUMB 250mg

Rave Kratom Targeted Kratom Extract Gummies NUMB 250mg is the second addition to the Targeted Gummy product line. This time, Rave is taking a page out of the book and utilizing the super popular kratom and kava combination from their 2oz NUMB Shot. Although the kratom and kava combination has been used for centuries by the native people, it is just becoming popular in the West!

Many users in the West call Kava nature’s alcohol as it mirrors some of the effects but without side effects or hangovers! Kava is known for loosening users up, increasing sociability, and providing a profound calming effect. It has been discovered that pairing these two plant-based medicines together provides a wide array of entourage effects and works synergistically for an even deeper calming feeling.

Kratom is typically touted for its energizing effects, but in the proper dosages, it can also provide sedative-like effects. This combination is a no-brainer for users looking to experience maximum relaxation. One might even say this blend puts users into a state of being comfortably NUMB!

Rave Kratom Targeted Kratom Extract Gummies come in a 10ct jar. Every juicy, sugar-dusted, Sour-grape-flavored gummy includes Rave’s NUMB formula! This formula utilizes a 1:1 ratio of 25mg of kratom extract to 25mg of Kava Extract. Each bottle contains 250mg of each total.

This is the perfect gummy blend for users who enjoy kratom’s more relaxed effects. This blend has been used for centuries in ceremonies and other events. In modern times, this blend is excellent for users interested in relaxation and helping aid in easing stress and anxiety.

Product Features:

• Available In A 10ct Child-Proof Jar (250mg Kratom Extract + 250mg Kava)
• Each Gummy Contains A 1:1 Ration Of 25mg Kratom To 25mg Kava
• Sour Grape Flavor
• Made Using 80% Full Spectrum Kratom Extract
• Water-Based Extract
• GMP Certified + Third Party Lab Tested

Lab Analysis: Coming Soon